These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 23383076)

  • 1. Intravenous N-acetylcysteine for prevention of contrast-induced nephropathy: a meta-analysis of randomized, controlled trials.
    Sun Z; Fu Q; Cao L; Jin W; Cheng L; Li Z
    PLoS One; 2013; 8(1):e55124. PubMed ID: 23383076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-acetylcysteine and contrast-induced nephropathy: a meta-analysis of 13 randomized trials.
    Zagler A; Azadpour M; Mercado C; Hennekens CH
    Am Heart J; 2006 Jan; 151(1):140-5. PubMed ID: 16368307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review of the impact of N-acetylcysteine on contrast nephropathy.
    Pannu N; Manns B; Lee H; Tonelli M
    Kidney Int; 2004 Apr; 65(4):1366-74. PubMed ID: 15086476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theophylline for prevention of contrast-induced nephropathy: a systematic review and meta-analysis.
    Bagshaw SM; Ghali WA
    Arch Intern Med; 2005 May; 165(10):1087-93. PubMed ID: 15911721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysis.
    Nallamothu BK; Shojania KG; Saint S; Hofer TP; Humes HD; Moscucci M; Bates ER
    Am J Med; 2004 Dec; 117(12):938-47. PubMed ID: 15629733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-acetylcysteine for the prevention of contrast-induced nephropathy in patients with pre-existing renal insufficiency or diabetes: a systematic review and meta-analysis.
    Kang X; Hu DY; Li CB; Ai ZS; Peng A
    Ren Fail; 2015 Nov; 37(10):297-303. PubMed ID: 26458505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy.
    Zoungas S; Ninomiya T; Huxley R; Cass A; Jardine M; Gallagher M; Patel A; Vasheghani-Farahani A; Sadigh G; Perkovic V
    Ann Intern Med; 2009 Nov; 151(9):631-8. PubMed ID: 19884624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-acetylcysteine versus ascorbic acid or N-acetylcysteine plus ascorbic acid in preventing contrast-induced nephropathy: A meta-analysis.
    Feng Y; Huang X; Li L; Chen Z
    Nephrology (Carlton); 2018 Jun; 23(6):530-538. PubMed ID: 28452187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prophylaxis of contrast-induced nephropathy with N-acetylcysteine].
    Gawenda M; Möller A; Wassmer G; Brunkwall J
    Zentralbl Chir; 2007 Jun; 132(3):227-31. PubMed ID: 17610195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy of pharmacological interventions for contrast-induced nephropathy prevention after coronary angiography: a network meta-analysis from randomized trials.
    Ma WQ; Zhao Y; Wang Y; Han XQ; Zhu Y; Liu NF
    Int Urol Nephrol; 2018 Jun; 50(6):1085-1095. PubMed ID: 29404930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral N-acetylcysteine for prophylaxis of contrast-induced nephropathy in patients following coronary angioplasty: A meta-analysis.
    Li JX; Jin EZ; Yu LH; Li Y; Liu NN; Dong YM; Li X; Li XQ
    Exp Ther Med; 2017 Aug; 14(2):1568-1576. PubMed ID: 28810622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrarenal application of N-acetylcysteine for the prevention of contrast medium-induced nephropathy in primary angioplasty.
    Aslanger E; Uslu B; Akdeniz C; Polat N; Cizgici Y; Oflaz H
    Coron Artery Dis; 2012 Jun; 23(4):265-70. PubMed ID: 22343798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial of intravenous n-acetylcysteine to prevent contrast induced nephropathy in acute coronary syndromes.
    Jaffery Z; Verma A; White CJ; Grant AG; Collins TJ; Grise MA; Jenkins JS; McMullan PW; Patel RA; Reilly JP; Thornton SN; Ramee SR
    Catheter Cardiovasc Interv; 2012 May; 79(6):921-6. PubMed ID: 21542122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of short-term infusion regimens of N-acetylcysteine plus intravenous fluids, sodium bicarbonate plus intravenous fluids, and intravenous fluids alone for prevention of contrast-induced nephropathy in the emergency department.
    Kama A; Yılmaz S; Yaka E; Dervişoğlu E; Doğan NÖ; Erimşah E; Pekdemir M
    Acad Emerg Med; 2014 Jun; 21(6):615-22. PubMed ID: 25039544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium bicarbonate therapy for prevention of contrast-induced nephropathy: a systematic review and meta-analysis.
    Navaneethan SD; Singh S; Appasamy S; Wing RE; Sehgal AR
    Am J Kidney Dis; 2009 Apr; 53(4):617-27. PubMed ID: 19027212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness of N-Acetylcysteine in preventing contrast-induced nephropathy in patients undergoing contrast-enhanced computed tomography: a meta-analysis of randomized controlled trials.
    Wu MY; Hsiang HF; Wong CS; Yao MS; Li YW; Hsiang CY; Bai CH; Hsu YH; Lin YF; Tam KW
    Int Urol Nephrol; 2013 Oct; 45(5):1309-18. PubMed ID: 23283594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of N-acetylcysteine plus sodium bicarbonate in the prevention of contrast-induced nephropathy after cardiac catheterization and percutaneous coronary intervention: A meta-analysis of randomized controlled trials.
    Zhao SJ; Zhong ZS; Qi GX; Tian W
    Int J Cardiol; 2016 Oct; 221():251-9. PubMed ID: 27404685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized controlled trial of intravenous N-acetylcysteine for the prevention of contrast-induced nephropathy after cardiac catheterization: lack of effect.
    Webb JG; Pate GE; Humphries KH; Buller CE; Shalansky S; Al Shamari A; Sutander A; Williams T; Fox RS; Levin A
    Am Heart J; 2004 Sep; 148(3):422-9. PubMed ID: 15389228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium bicarbonate plus N-acetylcysteine prophylaxis: a meta-analysis.
    Brown JR; Block CA; Malenka DJ; O'Connor GT; Schoolwerth AC; Thompson CA
    JACC Cardiovasc Interv; 2009 Nov; 2(11):1116-24. PubMed ID: 19926054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of contrast-induced nephropathy with N-acetylcysteine or sodium bicarbonate in patients with ST-segment-myocardial infarction: a prospective, randomized, open-labeled trial.
    Thayssen P; Lassen JF; Jensen SE; Hansen KN; Hansen HS; Christiansen EH; Junker A; Ravkilde J; Thuesen L; Veien KT; Jensen LO
    Circ Cardiovasc Interv; 2014 Apr; 7(2):216-24. PubMed ID: 24714489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.